Interestingly, evaluation of genes expression ratio between tumor vs. normal tissues of non-BCR and BCR prostate cancer patients identified significantly lower tumor vs. normal ratios for ERG variants and TMPRSS2-ERG fusion transcripts, as well as for TP53, HDAC1, and PTEN in BCR cases. The gene discussed is TP53; the disease is prostate carcinoma.